검색어 : 통합검색[637.1]
총 1,304건 중 1,000건 출력
, 4/100 페이지
-
31
- Frequency stabilization of diode laser to 1.637 mum based on the methane absorption line
- Ma, W.; Dong, L.; Yin, W.; Li, C.; Jia, S.; ; (Chinese optics letters : COL, v.2, 2004, pp.486-488)
-
32
- International cooperation in Maritime casualty Investigations: an analysis of IMO RESOLUTION A.637 (1 6)
- Sobey, Michael J.; ; (Maritime policy and management, v.20, 1993, pp.3-29)
-
33
- Possible site of action of TAK-637, a tachykinin NK<sub>1</sub> receptor antagonist, on the micturition reflex in guinea pigs
- Kamo, Izumi; Imai, Shigemitsu; Okanishi, Satoshi; Doi, Takayuki; Corresponding author. Tel.: +81-06-6300-6210; fax: +81-06-6300-6306; Pharmaceutical Research Division, Takeda Chemical Industries Ltd., 2-17-85, Jusohonmachi, Yodogawa-ku, Osaka 532-8686, Japan; Pharmaceutical Research Division, Takeda Chemical Industries Ltd., 2-17-85, Jusohonmachi, Yodogawa-ku, Osaka 532-8686, Japan; Pharmaceutical Research Division, Takeda Chemical Industries Ltd., 2-17-85, Jusohonmachi, Yodogawa-ku, Osaka 532-8686, Japan; (European journal of pharmacology, v.401, 2000, pp.235-240)
-
34
- The phosphorylation status of Ser-637 in dynamin-related protein 1 (Drp1) does not determine Drp1 recruitment to mitochondria
- Yu, Rong; Liu, Tong; Ning, Chenfei; Tan, Fei; Jin, Shao-Bo; Lendahl, Urban; Zhao, Jian; Nisté r, Monica; Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden; Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden; Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden; Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden; Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden; (The Journal of biological chemistry, v.294, 2019, pp.17262-17277)
-
35
- Hsp90 induces Acsl4-dependent glioma ferroptosis via dephosphorylating Ser637 at Drp1
- Miao, Zong; Tian, Wei; Ye, Yangfan; Gu, Wei; Bao, Zhongyuan; Xu, Lei; Sun, Guangchi; Li, Chong; Tu, Yiming; Chao, Honglu; Lam, Sin Man; Liu, Ning; Ji, Jing; Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; Department of Neurosurgery, The Affiliated Wuxi No.2 People’s Hospital of Nanjing Medical University, Wuxi, China; Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; Department of Neurosurgery, The Affiliated Wuxi No.2 People’s Hospital of Nanjing Medical University, Wuxi, China; Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; Department of Neurosur; (Cell death & disease, v.13, 2022, pp.548)
-
36
- 637. Targeting of Myeloid Leukemia by IL-10-Engineered Human CD4+ Tr1 Cells
- Locafaro, Grazia; Andolfi, Grazia; Russo, Fabio; Camisa, Barbara; Ciceri, Fabio; Lombardo, Angelo; Bondanza, Attilio; Roncarolo, Maria Grazia; Gregori, Silvia; ; (Molecular therapy : the journal of the American Society of Gene Therapy, v.24, 2016, pp.S252)
-
37
- Microbial synthesis of a deuterium-labelled metabolite of an NK1 receptor antagonist, TAK-637
- Tarui, Naoki; Ikeura, Yoshinori; Natsugari, Hideaki; Nakahama, Kazuo; Pharmaceutical Research Division, Takeda Chemical Industries, Ltd., 2-17-85, Jusohonmachi, Yodogawa-ku, Osaka 532-8686, Japan; Pharmaceutical Research Division, Takeda Chemical Industries, Ltd., 2-17-85, Jusohonmachi, Yodogawa-ku, Osaka 532-8686, Japan; Pharmaceutical Research Division, Takeda Chemical Industries, Ltd., 2-17-85, Jusohonmachi, Yodogawa-ku, Osaka 532-8686, Japan; Pharmaceutical Research Division, Takeda Chemical Industries, Ltd., 2-17-85, Jusohonmachi, Yodogawa-ku, Osaka 532-8686, Japan; (Journal of labelled compounds & radiopharmaceuticals, v.44, 2001, pp.865-870)
-
38
- 637 Non-redundant roles for GLUT1 and GLUT3 in melanoma and primary melanocytes
- Yang, R.; Yu, D.; Kim, J.; Lee, E.; Mahapatra, R.; Wang, R.C.; ; (Journal of investigative dermatology, v.142, 2022, pp.S110)
-
39
- 637 Microbiome-induced S1P released from keratinocytes promotes antimicrobial activity in mast cells
- Chang, Y.; Wang, Z.; Mascarenhas, N.; Di Nardo, A.; ; (Journal of investigative dermatology, v.137, 2017, pp.S110)
-
40
- Calendar-<b>7</b><b>6</b>(1-6), 324 (N), 637 (N), 979 (N), 1273 (N), 1586 (N), 1868 (N).
- ; ; (The Journal of the Acoustical Society of America, v.76, 1984, pp.324-325)
QUICK MENU
